Clinical Trials in Nashville

Showing 14601-14620 of 20,298 trials

The Treatment of Glabellar Frown Lines

NCT02096081

The purpose of this study is to show that two FDA-approved botulinum toxin drugs called Xeomin® and Botox® can reduce the severity of vertical lines (wrinkles) that appear between the eyebrows (glabellar frown lines).

Glabellar Frown Lines

Merz North America, Inc.250 participantsStarted Feb 2014

Los Angeles, California, United States • Sacramento, California, United States • Santa Monica, California, United States +7 more locations

COMPLETEDPhase 3< 1 mile

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

NCT00056160

Randomized subjects will receive CC-5013 plus high-dose dexamethasone or placebo appearing identical to CC-5013 plus high-dose dexamethasone in 4-week cycles. Each subject will participate in a treatment phase and a follow-up phase.

Multiple Myeloma

Celgene353 participantsStarted Jan 2003

Hoover, Alabama, United States • Duarte, California, United States • Los Angeles, California, United States +46 more locations

The Treatment of Glabellar Frown Lines

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Find Trials by Condition in Nashville

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

Dose Ranging Safety and Efficacy of Therapeutic HSV-2 Vaccine

A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

The Vascutek AnacondaTM Stent Graft System Phase II IDE Study

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

Clinical and Genetic Characterization of Individuals With Achromatopsia

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy

Radial Strain ECHO-Guided Implantation of Cardiac Resynchronization Therapy

Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients With Myelofibrosis

Study of the Consumer Use of a New Home Test to Measure Sperm Concentration

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer